1. Metronomic Chemotherapy Modulates Clonal Interactions to Prevent Drug Resistance in Non-Small Cell Lung Cancer
   Maryna Bondarenko et al, 2021, Cancers CrossRef
2. Dose‐dependent bidirectional pharmacological effects of vinorelbine‐based metronomic combination chemotherapy on tumor growth and metastasis and mechanisms in melanoma mouse model
   Hua Liu et al, 2024, Fundamental & Clinical Pharmacology CrossRef
3. Effective dose window for containing tumor burden under tolerable level
   M. A. Masud et al, 2023, npj Systems Biology and Applications CrossRef
4. Mathematical Modeling Support for Lung Cancer Therapy—A Short Review
   Jaroslaw Smieja, 2023, International Journal of Molecular Sciences CrossRef
5. Metronomic chemotherapy and drug repurposing: A paradigm shift in oncology
   Nusrat Jan et al, 2024, Heliyon CrossRef
6. Induced Vascular Normalization—Can One Force Tumors to Surrender to a Better Microenvironment?
   Xu Xin Sun et al, 2023, Pharmaceutics CrossRef
7. Metronomic Anti-Cancer Therapy: A Multimodal Therapy Governed by the Tumor Microenvironment
   Raquel Muñoz et al, 2021, Cancers CrossRef
8. Versatile flexible micelles integrating mucosal penetration and intestinal targeting for effectively oral delivery of paclitaxel
   Chao Liu et al, 2023, Acta Pharmaceutica Sinica B CrossRef
9. Low-dose metronomic chemotherapy triggers oxidized mtDNA sensing inside tumor cells to potentiate CD8+T anti-tumor immunity
   Wen Qiao et al, 2023, Cancer Letters CrossRef
10. In situ photo‐crosslinked hydrogels prepared from acrylated 4‐arm‐poly(ethylene glycol)‐poly(ε‐caprolactone) block copolymers for local cancer therapy
    Yuandou Wang et al, 2022, Polymers for Advanced Technologies CrossRef
11. Adjusting the dose of traditional drugs combined with immunotherapy: reshaping the immune microenvironment in lung cancer
    Linlin Wang et al, 2023, Frontiers in Immunology CrossRef